Crystallization of bi-functional ligand protein complexes.

Area of Science:

• Biochemistry
• Structural Biology
• Drug Design

Background:

• Protein homodimerization is vital for signal transduction and other biological processes.
• Structural information is crucial for designing molecules that modulate signaling pathways.
• Crystallization of proteins with dimerization-inducing ligands is a key strategy.

Purpose of the Study:

• To evaluate the crystallizability of protein complexes formed with mono-functional and bi-functional ligands.
• To explore the use of bi-functional drugs for controlling protein dimerization and obtaining structural data.
• To investigate the impact of linker properties and ligand-enzyme ratios on crystallization and complex formation.

Main Methods:

• Chemical synthesis of bi-functional drugs by linking two ligands.
• Crystallization of matrix metalloproteinases (MMP-12 and MMP-9) with mono- and bi-functional ligands.
• Structure determination of seven ligand-dimerized complexes using various linkers and stoichiometric ratios.

Main Results:

• Bi-functional ligands present challenges but offer significant advantages for protein crystallization.
• Flexible and rigid linkers enable control over crystal packing and protein-ligand stoichiometry.
• Varying linker nature and attachment points provides structural insights into protein-ligand and linker-protein interactions.
• Successful crystallization and structure determination of seven distinct ligand-dimerized complexes were achieved.

Conclusions:

• Bi-functional drugs are effective tools for controlling protein dimerization and facilitating crystallization.
• The strategy of using bi-functional ligands can be broadly applied to drug design beyond protein dimerization.
• This approach enhances the ability to obtain structural information for rational drug development.